| Potential of solid lipid nanoparticles in brain targeting IP Kaur, R Bhandari, S Bhandari, V Kakkar Journal of Controlled release 127 (2), 97-109, 2008 | 730 | 2008 |
| Probiotics: potential pharmaceutical applications IP Kaur, K Chopra, A Saini European Journal of Pharmaceutical Sciences 15 (1), 1-9, 2002 | 681 | 2002 |
| Vesicular systems in ocular drug delivery: an overview IP Kaur, A Garg, AK Singla, D Aggarwal International journal of pharmaceutics 269 (1), 1-14, 2004 | 562 | 2004 |
| Ocular preparations: the formulation approach I Pal Kaur, M Kanwar Drug development and industrial pharmacy 28 (5), 473-493, 2002 | 393 | 2002 |
| Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin V Kakkar, S Singh, D Singla, IP Kaur Molecular nutrition & food research 55 (3), 495-503, 2011 | 392 | 2011 |
| Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery IP Kaur, R Smitha Drug development and industrial pharmacy 28 (4), 353-369, 2002 | 388 | 2002 |
| Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system D Aggarwal, IP Kaur International journal of pharmaceutics 290 (1-2), 155-159, 2005 | 313 | 2005 |
| Acetazolamide: future perspective in topical glaucoma therapeutics IP Kaur, R Smitha, D Aggarwal, M Kapil International journal of pharmaceutics 248 (1-2), 1-14, 2002 | 241 | 2002 |
| Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats V Kakkar, SK Muppu, K Chopra, IP Kaur European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 339-345, 2013 | 229 | 2013 |
| Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain V Kakkar, IP Kaur Food and chemical toxicology 49 (11), 2906-2913, 2011 | 218 | 2011 |
| Spanlastics—A novel nanovesicular carrier system for ocular delivery S Kakkar, IP Kaur International journal of pharmaceutics 413 (1-2), 202-210, 2011 | 198 | 2011 |
| Nanotherapy for posterior eye diseases IP Kaur, S Kakkar Journal of Controlled Release 193, 100-112, 2014 | 192 | 2014 |
| Topical delivery of antifungal agents IP Kaur, S Kakkar Expert opinion on drug delivery 7 (11), 1303-1327, 2010 | 189 | 2010 |
| Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles R Bhandari, IP Kaur International journal of pharmaceutics 441 (1-2), 202-212, 2013 | 180 | 2013 |
| Assessment of the variation in menopausal symptoms with age, education and working/non-working status in north-Indian sub population using menopause rating scale (MRS) V Kakkar, D Kaur, K Chopra, A Kaur, IP Kaur Maturitas 57 (3), 306-314, 2007 | 179 | 2007 |
| Formulation and evaluation of ophthalmic preparations of acetazolamide IP Kaur, M Singh, M Kanwar International journal of pharmaceutics 199 (2), 119-127, 2000 | 178 | 2000 |
| Sesamol exhibits antimutagenic activity against oxygen species mediated mutagenicity IP Kaur, A Saini Mutation Research/Genetic Toxicology and Environmental Mutagenesis 470 (1 …, 2000 | 171 | 2000 |
| Curcumin loaded solid lipid nanoparticles ameliorate adjuvant‐induced arthritis in rats R Arora, A Kuhad, IP Kaur, K Chopra European journal of pain 19 (7), 940-952, 2015 | 158 | 2015 |
| Development of a topical niosomal preparation of acetazolamide: preparation and evaluation D Aggarwal, A Garg, IP Kaur Journal of Pharmacy and Pharmacology 56 (12), 1509-1517, 2004 | 155 | 2004 |
| Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice M Anjaneyulu, K Chopra, I Kaur Journal of medicinal food 6 (4), 391-395, 2003 | 155 | 2003 |
Praveen RishiProfessor of Microbiology, Panjab University, ChandigarhVerified email at pu.ac.in
